Development of a multi-marker model combining HE4, CA125, progesterone, and estradiol for distinguishing benign from malignant pelvic masses in postmenopausal women

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
Pengjun ZhangYaping Tian

Abstract

The purpose of this study was to evaluate HE4, CA125, progesterone (Prog), and estradiol (E2) for differentiating pelvic masses in postmenopausal women and aimed to build a multi-marker model which may improve the diagnostic value. HE4, CA125, Prog, and E2 were detected in 57 benign pelvic masses (BPM) and 92 epithelial ovarian cancer (EOC) patients. A total of 66.66 % of the BPM and EOC serum samples were used for building the differentiation model, and the remaining 33.33 % of the BPM and EOC serum samples were used for validation of the differentiation model. After comparing by Z score statistics, HE4 + CA125 + E2 model was chosen as the best multi-marker model. In the training group, the area under curve of the HE4 + CA125 + E2 model was 0.97 (0.93, 1.00), sensitivities of the model for distinguishing BPM from EOC, from early EOC, and from advanced EOC were 90.16, 86.21, and 95.65 %; specificities were 92.11, 92.11, and 92.11 %. In the validation group, sensitivities of HE4 + CA125 + E2 model for distinguishing BPM from EOC, from early EOC, and from advanced EOC were 96.77, 100.00, and 87.50 %, specificities were 84.21, 100.00, and 84.21 %. The multi-marker model showed significant improvement when compared to CA125 or HE4,...Continue Reading

References

Dec 1, 1994·Gynecologic Oncology·J P Curtin
Feb 13, 2001·Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology·D TimmermanUNKNOWN International Ovarian Tumor Analysis (IOTA) Group
Mar 7, 2001·In Vitro Cellular & Developmental Biology. Animal·W BaiS V Nicosia
Aug 14, 2001·Journal of Cellular Biochemistry·S YuJ Park
Mar 14, 2002·Clinical Cardiology·William F FearonVictor F Froelicher
May 14, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert C Bast
Oct 28, 2003·Reproductive Biology and Endocrinology : RB&E·Shuk-Mei Ho
May 9, 2007·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Dmitrijus KirilovasKjell Carlström
May 27, 2008·Toxicological Sciences : an Official Journal of the Society of Toxicology·Daniel A SymondsJodi A Flaws
Apr 2, 2010·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Emanuela AnastasiMaria Gabriella Reale
Feb 23, 2011·International Journal of Molecular Sciences·Emanuela AnastasiCecilia Midulla
Mar 23, 2011·Gynecologic Oncology·Francis JacobViola Heinzelmann-Schwarz
May 12, 2011·Clinica Chimica Acta; International Journal of Clinical Chemistry·Giuseppina RuggeriSergio Pecorelli
Sep 16, 2011·Journal of the National Cancer Institute·Nicole UrbanCharles W Drescher
Apr 25, 2012·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Teresa GranatoEmanuela Anastasi
May 11, 2012·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Robert C BastRichard G Moore
Oct 16, 2012·Gynecologic Oncology·Karen K L ChanWalfrido W Sumpaico
Dec 12, 2012·European Journal of Obstetrics, Gynecology, and Reproductive Biology·JiaYing LinVoramon Sangvatanakul
Feb 22, 2013·Journal of Clinical Pathology·Simona FerraroMauro Panteghini
Jun 1, 2013·Archives of Gynecology and Obstetrics·Rafal MoszynskiStefan Sajdak
Jul 13, 2013·The Lancet Oncology·Charlie Gourley
Nov 8, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Ting LiuWen Di
Jan 9, 2014·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Jan 29, 2014·International Journal of Cancer. Journal International Du Cancer·Laura A LavioletteBarbara C Vanderhyden
Sep 18, 2014·The Journal of Obstetrics and Gynaecology Research·Jing LiaoDing Ma
Jun 1, 2013·Journal of Cancer Prevention·Kyung Hee HanYong Sang Song
Jan 15, 2015·Journal of Molecular Endocrinology·Caroline H DiepCarol A Lange
Apr 22, 2015·Clinica Chimica Acta; International Journal of Clinical Chemistry·Teresa GranatoEmanuela Anastasi

❮ Previous
Next ❯

Citations

Jun 3, 2020·International Journal of Medical Informatics·Mingyang LuJingting Jiang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.